Cannabis Cost of Capital
The above-market interest rates and dilution premiums cannabis operators pay due to limited banking access and elevated execution risk.
Definition
Cannabis Cost of Capital refers to the elevated rates at which plant-touching operators access debt and equity financing relative to comparable non-cannabis businesses. Senior secured debt for MSOs has historically priced 700–1,200 basis points above comparable B-rated corporate debt (often 12–15% coupons). Equity issuances by U.S. MSOs price at substantial discounts to comparable consumer or healthcare names given OTC listing constraints, shallow institutional bid, and 280E earnings drag.
Also known as: WACC (Cannabis), Cannabis financing cost
Why It Matters for Investors
Cost of capital is the binding constraint on cannabis growth strategy. Operators with positive free cash flow can self-fund expansion; those still burning cash face highly dilutive equity raises or above-15% coupon debt. Rescheduling, SAFE Banking, and uplisting would all materially compress sector cost of capital — and the equity markets price in this optionality whenever catalyst probability shifts.
Track the 88 cannabis equities behind every term in this glossary
Get the daily CIN brief — pre-open, midday, and close. Always free.
Get the Brief